Navigation Links
Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older
Date:12/22/2010

NEW YORK, Dec. 22, 2010 /PRNewswire/ -- Pfizer Inc (NYSE: PFE) today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

The FDA is targeting a review cycle of 10 months from the application's submission date, resulting in an expected action date in October 2011, subject to the FDA's acceptance of the application. The EMA will follow the centralized procedure for review of Pfizer's application.  

"We are pleased to be another step closer to potentially bringing Prevnar 13 to adults aged 50 and older," says Emilio Emini, PhD, chief scientific officer, Vaccine Research, Pfizer. "These milestones are further examples of the company's commitment to help prevent pneumococcal disease through vaccination and to improve health and well-being at every stage of life."  

Prevnar 13, which is based on the scientific foundation of Prevnar®** (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), was approved for use in infants and young children in Europe in December 2009 and in the United States in February 2010. Like Prevnar, Prevnar 13 uses conjugate technology that has been shown to confer a high antibody response in infants and toddlers.

In the United States, Pfizer is seeking approval from the FDA to market Prevnar 13 for the active immunization of adults 50 years of age and older for the prevention of pneumococcal disease (including pneumonia and invasi
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
2. Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman
3. Pfizer Declares A 20-Cent First-Quarter 2011 Dividend
4. Young Children In Developing World Receive Accelerated Access to Pfizers Prevenar 13 Vaccine
5. Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
6. Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
7. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
8. Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds
9. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
10. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
11. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Ill. , June 18, 2013 /PRNewswire-iReach/ -- ... its new X3130 Appliance Inlet Module. The X3130, ... breaker , combines a C14 appliance inlet module, ... compact package.  This three-in-one device allows design engineers ... designs - cutting installation time by 66 percent ...
(Date:6/18/2013)... , June 18, 2013  It has become ... Alliance Seating and Mobility, a subsidiary company of ... timely repair. This appears to be due to ... of field service employees.  (Logo: ... many of these clients are complex mobility users ...
(Date:6/18/2013)...  Recent regulatory and budget challenges have made it ... large pharmaceutical companies to effectively educate doctors and other ... their new products. With the pressure to reduce budgets ... these "Med Ed" groups find practical, economical ... the changes that are transforming the Medical Education area ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
... SHANGHAI, Nov. 12, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech ... announced shareholder resolutions adopted at its annual general ... November 10, 2010. (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO) ... the meeting, WuXi PharmaTech shareholders approved the re-election ...
Cached Medicine Technology:HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2
(Date:6/19/2013)... Children had half as many emergency department ... hours on five or more days a week, according ... Mott Children,s Hospital and Johns Hopkins University. , The ... The Journal of Pediatrics and will be presented ... are an important step in understanding where primary care ...
(Date:6/19/2013)... Casual, no-strings sexual encounters are increasingly common on ... than others to "hook up"? A new study ... Behavioral and Preventive Medicine, published online by the ... are certain factors and behaviors associated with sexual ... "Given the potential for negative emotional and physical ...
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... at Louisiana State University have developed a method for ... relies on understanding the genetic interaction between single nucleotide ... prostate cancer,s aggressiveness to avoid unnecessary radical treatment. ... PLOS ONE in April. , According to ... all cancers and 9 percent of cancer deaths. It ...
(Date:6/19/2013)... June 19, 2013 Alternatives, a revolutionary ... patients to quit using drugs while allowing them to ... the founders of Alternatives, believe that abstinence-only approaches force ... enter treatment and that this approach hurts instead of ... in the United States need treatment for addiction but ...
Breaking Medicine News(10 mins):Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3
... effect of tiny nanoparticles on the health of the ... exhaust and are also used in making household goods ... scientists will assess if these particles damage liver cells. ... times smaller than the width of a human hair, ...
... Harris Interactive? for the Vagisil Women's Health CenterSM conducted a ... of today's American women are taking active roles in their ... thirds of women aged 18 and older (63 percent) report ... go to a gynecologist, 61 percent say they "always" go ...
... London. The overseas doctors in Britain are alarmed as new ... work permit before they can work// in hospitals of ... thousands of doctors from the Indian subcontinent who ... job vacancy if there are no local doctors available the ...
... afflict anyone, even the health conscious, but dying from ... study//. To make this happen, it would obviously warrant ... adopting nutritious food habits, regular exercise, and screenings as ... enabled by the American Cancer Society. ,Vilma ...
... the survey conducted by the Scottish executives large numbers of ... drinking. The researchers feel that memory loss is associated with ... vulnerable situations, becoming a target for rapists. ,This ... large percentage was losing their memories as a result of ...
... provided some useful tips on prevention of skin cancer ... risk factors and treatment. ,According to them ... skin cancer individuals who have a family history of ... because of certain inherited chromosomes and gene mutations. The ...
Cached Medicine News:Health News:Women aware of “feminine health” : their attitud 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3Health News:Did You Know That 50% Of Deaths Due To Cancer, Can be Prevented? 2Health News:Prevent Skin Cancer with Lifestyle Changes 2
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... Size: 4.0 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... cell sponge which is non-toxic and ... edges to minimize scleral intrusion. These ...
For use with E5381 700 Circling Band (240 style). 1.65 mm diameter, 30.0 mm long....
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Medicine Products: